Skip to content
Stock Focus Report

Stock Focus Report

Primary Menu
  • Home
  • Business
  • Economy
  • Domestic
  • Money
  • Politics
  • Top News
  • Newsletters
  • Home
  • 2025
  • April
  • 5
  • Musk and OpenAI jury trial to begin in spring next year

Musk and OpenAI jury trial to begin in spring next year

Stock Focus Report April 5, 2025
2025-04-04T232435Z_2_LYNXNPEL33184_RTROPTP_4_TECH-AI-OPENAI-MUSK

By Anna Tong

OAKLAND (Reuters) – – Billionaire Elon Musk’s lawsuit against OpenAI will go to a jury trial in spring 2026, the federal judge presiding over the case decided on Friday. 

Last month, OpenAI and Musk agreed to fast-track a trial over OpenAI’s for-profit shift, the latest turn in a grudge match between the world’s richest person and OpenAI CEO Sam Altman playing out publicly in court.

The judge, Yvonne Gonzalez Rogers of the U.S. District Court for the Northern District of California, had denied Musk’s request to pause the ChatGPT maker’s transition to a for-profit model and instead proposed an expedited trial.

Musk cofounded OpenAI with Altman in 2015 but left before the company took off and subsequently founded the competing startup xAI in 2023. xAI last month acquired Musk’s social media company X in a deal that values X at $33 billion and allows the value of his artificial intelligence firm to be shared with co-investors in X.

Last year, Musk, who is also the CEO of Tesla, sued OpenAI and Altman, accusing OpenAI of straying from its founding mission — to develop AI for the good of humanity, not corporate profit.

OpenAI and Altman have denied the allegations, while Altman alleges that Musk has been trying to slow down a competitor.

At stake in the lawsuit is the ChatGPT maker’s transition to a for-profit model, which the startup says is crucial to raising more capital and competing well in the expensive AI race.

OpenAI is under pressure to transition quickly. The company is currently raising a funding round of up to $40 billion led by Japanese tech investment group SoftBank. SoftBank said it has agreed to fund OpenAI with $10 billion in mid-April and an additional $30 billion in December, contingent on the firm’s transitioning to a for-profit by the end of the year.

Altman, who has said OpenAI is not for sale, rejected a $97.4 billion unsolicited takeover bid earlier this year from a Musk-led consortium with a “no thank you.”

(Reporting by Anna Tong in Oakland, California; Editing by Leslie Adler)


Continue Reading

Previous: Trading Day: Trump tariffs wipe $5 trillion off Wall Street
Next: US discusses tariffs, critical minerals, immigration with Pakistan

Live Market Pulse

The charting technology is provided by TradingView. Learn how to use theTradingView Stock Screener.

Recent Posts

  • UnitedHealth Suffers Sell-Off After Probe Surfaces
  • UnitedHealth shares slide as criminal probe report adds to investor fears
  • CVS bids for Rite Aid stores, patient data in Pacific Northwest, Bloomberg News reports
  • Hidden Gem’s – Tomorrow’s Market Secrets – Delivered Today
  • Amgen owes $406 million for monopolizing cholesterol drug market, US jury says

Categories

  • Business
  • Domestic
  • Economy
  • Money
  • Newsletters
  • Politics
  • Top News
  • Uncategorized

You may have missed

  • Newsletters

UnitedHealth Suffers Sell-Off After Probe Surfaces

Stock Focus Report May 15, 2025
2025-05-15T131423Z_4_LYNXMPEL4E0HS_RTROPTP_4_UNITEDHEALTH-DOJ.JPG
  • Business

UnitedHealth shares slide as criminal probe report adds to investor fears

Stock Focus Report May 15, 2025
2025-05-15T182409Z_1_LYNXMPEL4E118_RTROPTP_4_CVS-HEALTH-RESULTS
  • Business

CVS bids for Rite Aid stores, patient data in Pacific Northwest, Bloomberg News reports

Stock Focus Report May 15, 2025
  • Uncategorized

Hidden Gem’s – Tomorrow’s Market Secrets – Delivered Today

Stock Focus Report May 15, 2025
  • Home
  • Privacy Policy
  • Terms of Service/Use Agreement
  • Disclaimer
  • Contact Us
Copyright © All rights reserved. | MoreNews by AF themes.